Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04338295 · ClinicalTrials.gov registry record · NA
Follicular Revival in Treatment-resistant Alopecia Areata: Evaluating Use of Micro-needling
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT04338295 is a NA study that has completed, run by Yale University. The registered enrollment target is 5 participants.
The verdict
NCT04338295, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The investigators propose to study the efficacy of micro-needling via the SOL Nova Device in generating hair growth in patients with Alopecia Areta (AA) who are either non-responsive or only partially responsive to combination oral JAK inhibitor plus oral minoxidil therapy.
Interventions
- DEVICE Tattoo machine (SOL Nova Device)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2021-04-09 |
| Est. Completion | 2022-05-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04338295
The ClinicalTrials.gov registry entry for NCT04338295 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tattoo machine (SOL Nova Device) is the first listed.
NCT04338295 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04338295 about?
NCT04338295 is a clinical study titled "Follicular Revival in Treatment-resistant Alopecia Areata: Evaluating Use of Micro-needling". The investigators propose to study the efficacy of micro-needling via the SOL Nova Device in generating hair growth in patients with Alopecia Areta (AA) who are either non-responsive or only partially responsive to combination oral JAK inhibitor plus oral minoxidil therapy.
What is the current status of trial NCT04338295?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2021-04-09. Estimated completion is 2022-05-16.
What interventions are being tested in trial NCT04338295?
The interventions under investigation include: Tattoo machine (SOL Nova Device) (DEVICE).
Who is sponsoring clinical trial NCT04338295?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.